Literature DB >> 26416276

SHIP-1 Couples to the Dectin-1 hemITAM and Selectively Modulates Reactive Oxygen Species Production in Dendritic Cells in Response to Candida albicans.

Noelia Blanco-Menéndez1, Carlos Del Fresno1, Sandra Fernandes2, Enrique Calvo3, Ruth Conde-Garrosa1, William G Kerr2,4,5, David Sancho1.   

Abstract

Dectin-1 (Clec7a) is a paradigmatic C-type lectin receptor that binds Syk through a hemITAM motif and couples sensing of pathogens such as fungi to induction of innate responses. Dectin-1 engagement triggers a plethora of activating events, but little is known about the modulation of such pathways. Trying to define a more precise picture of early Dectin-1 signaling, we explored the interactome of the intracellular tail of the receptor in mouse dendritic cells. We found unexpected binding of SHIP-1 phosphatase to the phosphorylated hemITAM. SHIP-1 colocalized with Dectin-1 during phagocytosis of zymosan in a hemITAM-dependent fashion. Moreover, endogenous SHIP-1 relocated to live or heat-killed Candida albicans-containing phagosomes in a Dectin-1-dependent manner in GM-CSF-derived bone marrow cells (GM-BM). However, SHIP-1 absence in GM-BM did not affect activation of MAPK or production of cytokines and readouts dependent on NF-κB and NFAT. Notably, ROS production was enhanced in SHIP-1-deficient GM-BM treated with heat-killed C. albicans, live C. albicans, or the specific Dectin-1 agonists curdlan or whole glucan particles. This increased oxidative burst was dependent on Dectin-1, Syk, PI3K, phosphoinositide-dependent protein kinase 1, and NADPH oxidase. GM-BM from CD11c∆SHIP-1 mice also showed increased killing activity against live C. albicans that was dependent on Dectin-1, Syk, and NADPH oxidase. These results illustrate the complexity of myeloid C-type lectin receptor signaling, and how an activating hemITAM can also couple to intracellular inositol phosphatases to modulate selected functional responses and tightly regulate processes such as ROS production that could be deleterious to the host.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26416276      PMCID: PMC4641325          DOI: 10.4049/jimmunol.1402874

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.

Authors:  Neil C Rogers; Emma C Slack; Alexander D Edwards; Martijn A Nolte; Oliver Schulz; Edina Schweighoffer; David L Williams; Siamon Gordon; Victor L Tybulewicz; Gordon D Brown; Caetano Reis e Sousa
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

2.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.

Authors:  Olaf Gross; Andreas Gewies; Katrin Finger; Martin Schäfer; Tim Sparwasser; Christian Peschel; Irmgard Förster; Jürgen Ruland
Journal:  Nature       Date:  2006-07-12       Impact factor: 49.962

Review 3.  Inhibitory ITAMs as novel regulators of immunity.

Authors:  Ulrich Blank; Pierre Launay; Marc Benhamou; Renato C Monteiro
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

4.  Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages.

Authors:  Jenny M Tam; Michael K Mansour; Nida S Khan; Michael Seward; Sravanthi Puranam; Antoine Tanne; Anna Sokolovska; Christine E Becker; Mridu Acharya; Michelle A Baird; Augustine M K Choi; Michael W Davidson; Brahm H Segal; Adam Lacy-Hulbert; Lynda M Stuart; Ramnik J Xavier; Jatin M Vyas
Journal:  J Infect Dis       Date:  2014-05-19       Impact factor: 5.226

5.  Protein kinase Cδ is a critical component of Dectin-1 signaling in primary human monocytes.

Authors:  Deena H Elsori; Valentin P Yakubenko; Talat Roome; Praveena S Thiagarajan; Ashish Bhattacharjee; Satya P Yadav; Martha K Cathcart
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

6.  Regulation of alveolar macrophage p40phox: hierarchy of activating kinases and their inhibition by PGE2.

Authors:  Emilie Bourdonnay; Carlos H Serezani; David M Aronoff; Marc Peters-Golden
Journal:  J Leukoc Biol       Date:  2012-04-27       Impact factor: 4.962

7.  Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes.

Authors:  Andrew S J Marshall; Janet A Willment; Hsi-Hsien Lin; David L Williams; Siamon Gordon; Gordon D Brown
Journal:  J Biol Chem       Date:  2004-01-22       Impact factor: 5.157

8.  Differential use of CARD9 by dectin-1 in macrophages and dendritic cells.

Authors:  Helen S Goodridge; Takahiro Shimada; Andrea J Wolf; Yen-Michael S Hsu; Courtney A Becker; Xin Lin; David M Underhill
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 9.  Myeloid C-type lectins in innate immunity.

Authors:  Matthew J Robinson; David Sancho; Emma C Slack; Salomé LeibundGut-Landmann; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

Review 10.  C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways.

Authors:  Anthony Plato; Janet A Willment; Gordon D Brown
Journal:  Int Rev Immunol       Date:  2013-04       Impact factor: 5.311

View more
  23 in total

1.  Impaired phagocytosis directs human monocyte activation in response to fungal derived β-glucan particles.

Authors:  Giorgio Camilli; Elif Eren; David L Williams; Vishukumar Aimanianda; Etienne Meunier; Jessica Quintin
Journal:  Eur J Immunol       Date:  2018-02-05       Impact factor: 5.532

2.  Candida albicans triggers a differential profile of microRNAs depending on its growing form.

Authors:  Carlos Del Fresno Sánchez
Journal:  Virulence       Date:  2016-07-21       Impact factor: 5.882

3.  LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism.

Authors:  Raki Sudan; Sandra Fernandes; Neetu Srivastava; Chiara Pedicone; Shea T Meyer; John D Chisholm; Robert W Engelman; William G Kerr
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

4.  Candidalysin, a Virulence Factor of Candida albicans, Stimulates Mast Cells by Mediating Cross-Talk Between Signaling Pathways Activated by the Dectin-1 Receptor and MAPKs.

Authors:  Pu Song; Ge Peng; Hainan Yue; Takasuke Ogawa; Shigaku Ikeda; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  J Clin Immunol       Date:  2022-04-14       Impact factor: 8.542

Review 5.  Molecular Functions of Glycoconjugates in Autophagy.

Authors:  Kamau Fahie; Natasha E Zachara
Journal:  J Mol Biol       Date:  2016-06-23       Impact factor: 5.469

6.  Dectin-1 is required for miR155 upregulation in murine macrophages in response to Candida albicans.

Authors:  Daniel Paiva Agustinho; Marco Antônio de Oliveira; Aldo Henrique Tavares; Lorena Derengowski; Valentina Stolz; Fernanda Guilhelmelli; Márcia Renata Mortari; Karl Kuchler; Ildinete Silva-Pereira
Journal:  Virulence       Date:  2016-06-13       Impact factor: 5.882

7.  Syk negatively regulates TLR4-mediated IFNβ and IL-10 production and promotes inflammatory responses in dendritic cells.

Authors:  Hui Yin; Huaxin Zhou; Yi Kang; Xiaoju Zhang; Xiaoxian Duan; Ridab Alnabhan; Shuang Liang; David A Scott; Richard J Lamont; Jia Shang; Huizhi Wang
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 8.  Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity.

Authors:  Juan Tang; Guoxin Lin; Wallace Y Langdon; Lijian Tao; Jian Zhang
Journal:  Front Immunol       Date:  2018-02-01       Impact factor: 7.561

Review 9.  Targeting SHIP1 and SHIP2 in Cancer.

Authors:  Chiara Pedicone; Shea T Meyer; John D Chisholm; William G Kerr
Journal:  Cancers (Basel)       Date:  2021-02-20       Impact factor: 6.639

Review 10.  An Omics Perspective on Candida Infections: Toward Next-Generation Diagnosis and Therapy.

Authors:  S P Smeekens; F L van de Veerdonk; M G Netea
Journal:  Front Microbiol       Date:  2016-02-16       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.